WebApr 12, 2024 · On Tuesday, March 7th, Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock. The shares were sold at an average price of $10.13, for a total value … WebFeb 28, 2024 · Cytek Biosciences, Inc. SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex ...
Cytek Biosciences, Inc. (CTKB) Latest Press Releases
WebCYTEK BIOSCIENCES, INC. : Press releases relating to CYTEK BIOSCIENCES, INC. Investor relations Nasdaq: CTKB Nasdaq WebApr 12, 2024 · On Tuesday, March 7th, Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock. The shares were sold at an average price of $10.13, for a total value of $202,600.00. on running shoes grey
Cytek Biosciences to Participate in the Piper Sandler
WebApr 10, 2024 · Press release - QY Research, Inc - Spectral Flow Cytometry Market Size, Trend Analysis, Opportunities And Future Demand Foreseen by 2029 Sony Biotechnology, Cytek Biosciences, BD Biosciences ... WebFeb 28, 2024 · Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024. FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) ( Nasdaq: CTKB) today reported financial results for the fourth quarter and year ended December … WebApr 11, 2024 · The bottom line of Cytek Biosciences outpaced the Zacks Consensus Estimate in three of the trailing four quarters and matched the mark once, the average being 47.50%. The Zacks Consensus Estimate for CTKB’s 2024 earnings implies a rise of 66.7%, while the same for revenues indicates growth of 39.4% from the respective year-ago … on running shoes greece